JDD October Issue Highlights
Here are the issue highlights for the October issue of JDD!
Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you …
Here are the issue highlights for the October issue of JDD!
Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you … 
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni … 
Here are the issue highlights for the JDD August issue with special focus on Psoriasis:
Authors discuss the epidemiological, clinical, and histologic features of melasma and postinflammatory hyperpigmentation and important considerations for both established and emerging treatments in Therapeutic Insights in Melasma and Hyperpigmentation Management (CE credit is available)
Descriptive char … 
Dermatologists are well aware of the difficulty in managing itchy patients. Itch can be caused by a number of cutaneous and extracutaneous diseases. Regardless of the etiology, itch is one of the most frustrating symptoms of patients and management dilemmas for dermatologists. At the 16th Annual ODAC conference, Dr. Brian Berman reviewed some of the emerging therapies for the treatment of itch a … 